Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Scottsdale. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Scottsdale location
Access macular degeneration specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
Check if you qualify for this macular degeneration clinical trial in Scottsdale, AZ
No-Cost Study Care
Local to Scottsdale
Convenient for AZ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
ABBV-RGX-314 (also known as RGX-314) is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular degeneration (wet AMD). Wet AMD is characterized by loss of vision due to new, leaky blood vessel formation in the retina. Wet AMD is a significant cause of vision loss in the United States, Europe and Japan, with up to 2 million people living with wet AMD in these geographies alone. Current anti-vascular endothelial growth factor (VEGF) therapies ha
Sponsor: AbbVie
Yes, this clinical trial (NCT05407636) has an active research site in Scottsdale, AZ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for macular degeneration treatment options in Scottsdale, AZ, this clinical trial (NCT05407636) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Scottsdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all macular degeneration clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in Scottsdale — not just this study.
Browse Rheumatoid Arthritis Trials in Scottsdale →